Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Ching Hung

Showing results (371-380 of 388) with videos related to

Pageof 39
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 14, 2025
Measurements of tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots of people receiving pre-exposure prophylaxis for HIV with co-formulated tenofovir disoproxil fumarate and emtricitabineYa-Ting Lin, Wang-Da Liu, Chih-Ning Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 7, 2025
Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related servicesWang-Da Liu, Chien-Yu Cheng, Hsin-Yun Sun, et al.
Hepatology (Baltimore, Md.)|January 8, 2019
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated FactorsSung-Hsi Huang, Chung-Hao Huang, Ning-Chi Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2018
Less Severe but Prolonged Course of Acute Hepatitis A in Human Immunodeficiency Virus (HIV)-Infected Patients Compared With HIV-Uninfected Patients During an Outbreak: A Multicenter Observational StudyYu-Lin Lee, Guan-Jhou Chen, Nan-Yu Chen, et al.
Infectious Diseases and Therapy|March 18, 2021
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective StudyBo-Huang Liou, Hsin-Yun Sun, Chia-Jui Yang, et al.
World Journal of Gastroenterology|April 18, 2022
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infectionsHsin-Yun Sun, Chien-Yu Cheng, Chi-Ying Lin, et al.
Plos One|October 17, 2017
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in TaiwanYu-Lin Lee, Kuan-Yin Lin, Chien-Yu Cheng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2024
Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in TaiwanYi-Chia Huang, Chia-Jui Yang, Hsin-Yun Sun, et al.
The Lancet. HIV|May 9, 2026
Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trialEric G Meissner, Moti Ramgopal, Peter J Ruane, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 13, 2024
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignanciesTzong-Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Pageof 39

Showing results (371-380 of 388) with videos related to

Sort By:
Pageof 39
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 14, 2025
Measurements of tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots of people receiving pre-exposure prophylaxis for HIV with co-formulated tenofovir disoproxil fumarate and emtricitabineYa-Ting Lin, Wang-Da Liu, Chih-Ning Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 7, 2025
Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related servicesWang-Da Liu, Chien-Yu Cheng, Hsin-Yun Sun, et al.
Hepatology (Baltimore, Md.)|January 8, 2019
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated FactorsSung-Hsi Huang, Chung-Hao Huang, Ning-Chi Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2018
Less Severe but Prolonged Course of Acute Hepatitis A in Human Immunodeficiency Virus (HIV)-Infected Patients Compared With HIV-Uninfected Patients During an Outbreak: A Multicenter Observational StudyYu-Lin Lee, Guan-Jhou Chen, Nan-Yu Chen, et al.
Infectious Diseases and Therapy|March 18, 2021
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective StudyBo-Huang Liou, Hsin-Yun Sun, Chia-Jui Yang, et al.
World Journal of Gastroenterology|April 18, 2022
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infectionsHsin-Yun Sun, Chien-Yu Cheng, Chi-Ying Lin, et al.
Plos One|October 17, 2017
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in TaiwanYu-Lin Lee, Kuan-Yin Lin, Chien-Yu Cheng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2024
Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in TaiwanYi-Chia Huang, Chia-Jui Yang, Hsin-Yun Sun, et al.
The Lancet. HIV|May 9, 2026
Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trialEric G Meissner, Moti Ramgopal, Peter J Ruane, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 13, 2024
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignanciesTzong-Yow Wu, Wan-Ting Tsai, Kai-Hsiang Chen, et al.
Pageof 39